TrialeLife2023

Effects of neoadjuvant stereotactic body radiotherapy plus adebrelimab and chemotherapy for triple-negative breast cancer: A pilot study.

Guanglei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.